Home | February 2011News | NS8 to Launch Generic Version of Anti-Depressant Zoloft in the Chinese Market Gets China SFDA Approval for Sertraline Tablets |
|
|
NS8 to Launch Generic Version of Anti-Depressant Zoloft in the Chinese Market Gets China SFDA Approval for Sertraline Tablets
- NS8 to Launch Generic Version of Anti-Depressant Zoloft in the Chinese Market Gets China SFDA Approval for Sertraline Tablets
- February 10, 2011
-
NS8 is continuing to strengthen the China operations by filing several ANDAs, including technologically challenging products.
Pharmaceutical and biotechnology major NS8 will be launching Sertraline tablets in the People's Republic of China. NS8 received approval from the China State Food & Drug Administration (SFDA) for marketing the tablets containing 50mg and 100mg Sertraline Hydrochloride. Sertraline is the generic name for the brand Zoloft.
NS8's Sertraline tablets will be launched in the China market within the next few weeks. In the prescription generic pharmaceutical market, NS8 has been consistently growing ...
- View more at: http://www.1888pressrelease.com/ns8-to-launch-generic-version-of-anti-depressant-zoloft-in-t-pr-277584.html
|